21st Biosimilars Congregation 2026

21st Biosimilars Congregation 2026 is organized by Virtue Insight and will be held on Dec 10, 2026 at Kohinoor Continental, Mumbai, Maharashtra, India.

India’s biosimilars landscape is entering a phase of growth, driven by evolving regulatory pathways, market competition, and the need for greater access to biological treatments. As India strengthens its position as a biosimilar hub, focus is growing on cost competitiveness, scalable manufacturing, commercialisation, and global market alignment.

The 21st Biosimilars Congregation 2026 brings together industry leaders and experts to explore pricing, market access, affordability, intellectual property, portfolio planning, and payer expectations. Meanwhile, next-generation biosimilars, RWE, AI, and digital technologies are transforming development while strengthening physician confidence, patient trust, quality, and sustainable growth.

Who Should Attend 
CSOs, CMOs, Presidents, Vice Presidents, Heads, Directors, Team Leaders, and Senior Scientists from Biopharmaceuticals, Biotherapeutics, Follow-on Biologics, Biotechnology, Legal Affairs, Intellectual Property, Health Economics, Pricing & Reimbursement, Clinical Immunology, Regulatory, Quality, Analytical Technologies, New Product Development, Process Science, Portfolio Management, Research & Development, and Business Development.

What You'll Explore
Discover the latest biosimilar trends, regulatory developments, market strategies, technological innovations, and best practices shaping the future of biosimilars, patient access, affordability, and sustainable growth.

Key Themes, Emerging Trends and Strategic Discussions
• Regulatory Updates & Policy Shifts
• Market Access, Pricing & Affordability Strategies
• Role & Expectations of Payers
• Patent Landscape & IP Navigation in India
• Real-World Evidence (RWE) & PMS in India
• Patient Awareness & Education Initiatives
• Physician Trust & Clinical Confidence Building
• Quality Standards & Biosimilar Pharmacovigilance
• Digital Tools in Biosimilar R&D and Process Monitoring
• What’s the way forward? / Opportunity - Learn & Network
• Cost Competitiveness vs. Global Players
• Scaling Manufacturing / Development / Commercialisation
• Export Growth & Global Market Alignment
• Next-Gen Biosimilars & Technological Innovation

Featured Discussion Formats
Keynote Presentations
Learn from senior industry leaders sharing practical insights and global perspectives. Gain valuable strategies and real-world experiences shaping the future of pharmacovigilance.

Panel Discussions
Engage in expert-led discussions covering today's most pressing pharmacovigilance challenges. Exchange ideas, explore solutions, and learn from diverse industry perspectives.

Interactive Networking
Connect with peers, regulators, sponsors, and technology partners throughout the event. Build meaningful relationships that inspire collaboration and future business opportunities.

Why Join Us?
Expand Your Network Connect with global policymakers, industry leaders, and peers to exchange actionable insights across the biosimilars value chain.
Explore Innovative Solutions Discover emerging biosimilar technologies, AI applications, RWE approaches, and advanced strategies shaping the future of biological treatments.
Benchmark Your Strategy Benchmark your approach against industry frontrunners and gain perspectives on pricing, market access, regulation, and commercial strategy
Develop Actionable Plans Build immediate action plans to address R&D costs, regulatory barriers, market entry hurdles, and changing biosimilar competition.
Drive Business Growth Develop sustainable strategies that strengthen affordability, accessibility, innovation, and competitiveness while unlocking new commercial opportunities in biosimilars.